Start Searching Today!

Type a URL to search registration information about any website

COPAXONE Sign Up Information

Last Updated:
1/9/2020 1
Site Encrypted:
Yes
Site Category:
Email Verified:
20/100
Data Held

Email Address

 Email

Your Name

 First Name, Last Name

Your Address

 

Post-Registration Data

We are still gathering data about this website

Validation

This site did not show evidence of storing passwords in plaintext.

This site does allow secured connections (https)

This site did show a clear way to unsubscribe from their emails

This site does verify your email address.

Membership Emails

Below is a sample of the emails you can expect to receive when signed up to COPAXONE.

Make the most of Teva’s Shared Solutions® support by updating your information.
COPAXONE.com
Teva Pharmaceuticals USA, Inc,
COPAXONE® (glatiramer acetate injection) is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
Do not use COPAXONE® if you are allergic to glatiramer acetate or mannitol.
Prescribing Information | Important Safety Information
Teva’s Copaxone
 
MS Patient and caregiver
Have You Started
Your Therapy?
If you have recently started or switched to COPAXONE®, please update your information so Teva can send you information that’s relevant to your therapy experience. Remember, only COPAXONE® patients and their Care Partners can take full advantage of the resources and support offered by Teva’s Shared Solutions®.
Thank you for being part of Teva’s MS community.
Connect with us on the
Lift MS® Blog and Facebook
Lift MS Blog Lift MS Facebook
Important Safety Information
Do not use COPAXONE® if you are allergic to
glatiramer acetate or mannitol.
Serious side effects may happen right after or within minutes after you inject COPAXONE® at any time during your course of treatment. Call your doctor right away if you have any of these immediate post-injection reaction symptoms including: redness to your cheeks or other parts of the body (flushing); chest pain; fast heart beat; anxiety; breathing problems or tightness in your throat; or swelling, rash, hives, or itching. If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a doctor tells you to.
You can have chest pain as part of an immediate post-injection reaction or by itself. This type of chest pain usually lasts a few minutes and can begin around 1 month after you start using COPAXONE®. Call your doctor right away if you have chest pain while using COPAXONE®.
Damage to the fatty tissue just under your skin’s surface (lipoatrophy) and, rarely, death of your skin tissue (necrosis) can happen when you use COPAXONE®. Damage to the fatty tissue under your skin can cause a “dent” at the injection site that may not go away. You can reduce your chance of developing these problems by following your doctor’s instructions for how to use COPAXONE® and choosing a different injection area each time you use COPAXONE®.
The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the injection site; rash; shortness of breath; flushing; and chest pain.
Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of COPAXONE®. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please read the Patient Information in the full Prescribing Information.
COPAXONE.com | Unsubscribe | Privacy Notice | Legal Notice
Please note this message was sent to Busy40216@.
Teva Pharmaceuticals, 400 Interpace Parkway, Parsippany, NJ 07054
Teva Pharmaceuticals USA, Inc,
© 2019 Teva Pharmaceuticals USA, Inc. COP-46097 August 2019
Registration
I am living with MS
First name
Last name
Email
I am living with MS
What best describes you?
I care for someone with MS
I am living with MS
Someone I know has MS
I care for someone with MS
Yes
Daily COPAXONE® 20 mg
Yes
3-times-a-week COPAXONE® 40 mg
Daily COPAXONE® 20 mg
No
3-times-a-week COPAXONE® 40 mg
Yes
Daily COPAXONE® 20 mg
Yes
3-times-a-week COPAXONE® 40 mg
Daily COPAXONE® 20 mg
No
3-times-a-week COPAXONE® 40 mg
Yes
Daily COPAXONE® 20 mg
Yes
3-times-a-week COPAXONE® 40 mg
Daily COPAXONE® 20 mg
No
3-times-a-week COPAXONE® 40 mg
* I am 18 years of age or older.
Your privacy is important to us and the information you provide will be handled in accordance with our Privacy Notice.
* I agree to the statements below and have read and accept the Legal Notice and Privacy Notice. I authorize Teva Pharmaceuticals USA, Inc. (“Teva”), its affiliates and companies working with Teva to c
* I am 18 years of age or older.
Data Name Data Type Options
I am living with MS   Text Box
First name   Text Box
Last name   Text Box
Email   Text Box
I am living with MS   option What best describes you?
I care for someone with MS   option I am living with MS
Someone I know has MS   option I care for someone with MS
Yes   option
Daily COPAXONE® 20 mg   option Yes
3-times-a-week COPAXONE® 40 mg   option Daily COPAXONE® 20 mg
No   option 3-times-a-week COPAXONE® 40 mg
Yes   option
Daily COPAXONE® 20 mg   option Yes
3-times-a-week COPAXONE® 40 mg   option Daily COPAXONE® 20 mg
No   option 3-times-a-week COPAXONE® 40 mg
Yes   option
Daily COPAXONE® 20 mg   option Yes
3-times-a-week COPAXONE® 40 mg   option Daily COPAXONE® 20 mg
No   option 3-times-a-week COPAXONE® 40 mg
* I am 18 years of age or older.   checklist Your privacy is important to us and the information you provide will be handled in accordance with our Privacy Notice.
* I agree to the statements below and have read and accept the Legal Notice and Privacy Notice. I authorize Teva Pharmaceuticals USA, Inc. (“Teva”), its affiliates and companies working with Teva to c   checklist * I am 18 years of age or older.

Comments about copaxone

No Comments
Comment by: admin
Comment on: 01/09/2020